CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Zolpidem tartrate

Last Updated: March 7, 2013
Result type: Reports
Project Number: SR0314-000
Product Line: Reimbursement Review

Generic Name: Zolpidem tartrate

Brand Name: Sublinox

Manufacturer: Meda Valeant Pharma Canada Inc.

Therapeutic Area: Insomnia

Indications: Insomnia, short-term treatment

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 25, 2013

Recommendation Type: Do not list